PD Dr. med. Atiqullah Aziz, F.E.B.U., MBA

Chefarzt der Klinik für Urologie und Chirurgie

München Klinik Bogenhausen

Adresse

München Klinik Bogenhausen Englschalkinger Straße 77, 81925 München

„Ich möchte in der Klinik für Urologie Medizin auf universitärem Niveau anbieten. Das Wohl meiner Patientinnen und Patienten liegt mir am Herzen. Mit meinem Team möchte ich daher einen Beitrag zur exzellenten Gesundheitsversorgung in meiner Heimatstadt leisten.“
PD Dr. Atiqullah Aziz
  • Personalien >>
  • Facharzt für Urologie 
  • Fellow of the European Board of Urology
  • Master of Business Administration (Health Management)
  • Fachkunde Strahlenschutz
  • Röntgendiagnostik Harntrakt
  • Prüfarzt für klinische Studien
  • Sachkunde Laserschutz
  • Seit 03/2019
    Chefarzt der Klinik für Urologie, München Klinik Bogenhausen
  • 04/2017-03/2019:
    Oberarzt an der Klinik und Poliklinik für Urologie Universitätsmedizin Rostock
  • 01/2015-12/2017:
    Berufsbegleitendes Studium an der Universität Hamburg MBA Health Management
  • 26.10.2015:
    Habilitation und Verleihung der Venia legendi, Universitätsklinikum Hamburg-Eppendorf: Risikostratifizierung des Urothelkarzinoms der Harnblase anhand klinischer und histopathologischer Prognoseparameter
  • 06.06.2015:
    Fellow of the European Board of Urology
  • 06.05.2015:
    Anerkennung zum Facharzt für Urologie
  • 06/2014-03/2017:
    Assistenzarzt/Facharzt in der Klinik für Urologie, Universitätsklinikum Hamburg-Eppendorf
  • 09/2013-05/2014:
    Assistenzarzt (Rotation) in der Klinik für Kinderurologie der Universität Regensburg in der Klinik St. Hedwig
  • 01/2011-08/2013:
    Assistenzarzt in der Klinik für Urologie der Universität Regensburg am Caritas Krankenhaus St. Josef
  • 03/2010-12/2010:
    Assistenzarzt in der Abteilung für Allgemein- und Viszeralchirurgie der Chirurgischen Klinik München-Bogenhausen
  • 15.03.2010:
    Promotion zum Doktor medicinae: Perioperative hämodynamische Effekte des Angiotensin-I Converting-Enzyme Insertion/Deletion-Polymorphismus bei koronaren Bypassoperationen
  • 10/2003-11/2009:
    Studium der Humanmedizin an der Georg-August-Universität Göttingen
  • Roboterunterstützte Eingriffe bei Prostatakrebs und Nierenkrebs
  • Roboterunterstützte Eingriffe für rekonstruktive Chirurgie am Harntrakt
  • verschiedene Formen der Harnableitungen inklusive kontinente Harnableitungen (Neoblase, POUCH) bei Frauen und Männern
  • Minimal-invasive organ- und funktionserhaltende Tumorchirurgie
  • Radikale Zystektomie bei Harnblasenkrebs
  • rekonstruktive Urologie

 

Publikationen

                                                                                                   Als Erstautor (* = geteilte Erstautorschaft):

  • Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M and Roghmann F; PROMETRICS 2011 research group. Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort. Eur Urol. 2014 Jul;66(1):156-63.
  • Aziz A*, Shariat SF*, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int. 2014 Nov 10. doi: 10.1111/bju.12984. [Epub ahead of print]
  • Aziz A*, Gierth M*, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Elinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M and May M. Optimizing Outcome Reporting after Radical Cystectomy for Organ-confined Urothelial Carcinoma of the Bladder Using Oncological TRIFECTA and PENTAFECTA. World J Urol. 2015 [Epub ahead of print].
  • Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A and Burger M. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy. Urol Int. 2013;91(1):97-102.
  • Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S, Fritsche HM, Burger M, Gierth M. Comparative Analysis of Gender-Related Differences in Symptoms and Referral Patterns prior to Initial Diagnosis of Urothelial Carcinoma of the Bladder: A Prospective Cohort Study. Urol Int. 2015;94(1):37-44.
  • May M*, Aziz A*, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief C, Gilfrich C, Bastian PJ, Burger M and Fritsche HM. Prognostic Impact of Infiltration of the Vagina and/or Uterus in Female Patients undergoing Anterior Pelvic Exenteration for Urothelial Carcinoma of the Bladder: Results of a Contemporary Multicentre Series. World J Urol. 2015 Mar;33(3):343-50.
  • Fritsche HM, Aziz A*, Eder F, Otto W, Denzinger S, Wieland WF, May M, Hofstädter F, Hartmann A, Burger M. Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens. Virchows Arch. 2012 Dec;461(6):655-61.
  • Aziz A, Fritsche HM, Gakis G, Kluth LA, Al-Sayed F, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M and Rink M. Comparative Analysis of Comorbidity and Performance Indices for Prediction of Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma treated with Radical Nephroureterectomy. Urol Oncol. 2014 Nov;32(8):1141-50.
  • Aziz A*, Rink M*, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M and Fritsche HM. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Urol Int. 2014;93(3):352-60.
  • Aziz A*, May M*, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Martin MD, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C and Brookman-May S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group. Do Young Patients with Renal Cell Carcinoma Feature a Distinct Outcome after Surgery? A Comparative Analysis of Patient Age Based on the Multinational CORONA Database. J Urol. 2014 Feb;191(2):310-5.
  • May M*, Aziz A*, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C and Brookman-May S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database. World J Urol. 2013;31(5):1073-80.
  • Martini T*, Aziz A*, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C. Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study. Urol Int. 2016;96(1):57-64.
  • Aziz A, Milerski S, Kernig K, Protzel C, Hakenberg OW. [Lymph-node-positive penile cancer : Management and systemic therapy]. Urologe A. 2018 Apr;57(4):440-443.
  • Aziz A and Wieland WF. Erektile Dysfunktion: Was kann man(n) tun, wenn die Erektion ausbleibt? Der Allgemeinarzt, 03/2013; 35(5):34-39.
  • Aziz A, Herbst EM, Nowrotek A, Otto W, Brunner J, Gerber P, Wieland WF, Rößler W, Denzinger S. Die Argusschlinge ist schnell erlernbar. UroForum 06/2012, 3. Jahrgang, November/Dezember 2012:24-25 (eingeladene Arbeit nach Präsentation der Studienergebnisse im November 2012 auf dem 24. Kongress der Deutschen Kontinenz Gesellschaft in Würzburg).
  • Aziz A, Hakenberg OW. Immunonutrition in radical cystectomy: a novel approach to reduce postoperative complications?. Transl Androl Urol. 2018 Dec;7(Suppl 6):S718-S719. doi: 10.21037/tau.2018.10.06. PubMed PMID: 30687605; PubMed Central PMCID: PMC6323282.

                                                                                                                             Als Seniorautor:

  • Novotny V, Froehner M, May M, Protzel C, Hergenröther K, Rink M, Chun FK, Fisch M, Roghman F, Palisaar RJ, Noldus J, Gierth M, Fritsche HM, Burger M, Sikic D, Keck B, Wullich B, Nuhn P, Buchner A, Stief CG, Vallo S, Bartsch G, Haferkamp A, Bastian PJ, Hakenberg OW, Propping S and Aziz A. Risk-Stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2015 Feb 8. [Epub ahead of print]
  • Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland W, Giedl C, Hofstädter F, Rubenwolf P, Burger M and Aziz A. Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 122 patients. Urol Int. 2014;93(3):311-9.
  • May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief C, Bastian PJ and Aziz A. Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy. Ann Surg Oncol. 2014 Nov;21(12):4034-40.
  • M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM and Aziz A.  Body mass index has no impact on sperm quality but on reproductive hormones levels. Andrologia. 2014 Mar;46(2):106-11.
  • Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Eur Urol Focus. 2018 Mar;4(2):252-259.
  • Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2018 Jan;121(1):101-110.
  • Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study group. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort. Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817.
  • Vallo S, Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM, Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A, Fisch M, Aziz A. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder. Urol Oncol. 2016 Oct;34(10):432.e1-8.
  • Zamboni S, Moschini M, Simeone C, Antonelli A, Mattei A, Baumeister P, Xylinas E, Hakenberg OW, Aziz A. Prediction tools in non-muscle invasive bladder cancer. Transl Androl Urol. 2019 Feb;8(1):39-45. doi: 10.21037/tau.2019.01.15. Review. PubMed PMID: 30976567; PubMed Central PMCID: PMC6414347.

                                                                                                                                Als Koautor:

  • Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD and Shariat SF; Bladder Cancer Research Consortium. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int. 2013;111:30-6.
  • Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A and Burger M. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol. 2013;63(4):739-44.
  • Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ and Burger M. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med. 2012;9(6):481-9.
  • Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ and Burger M. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. World J Urol. 2014 Apr;32(2):365-71.
  • Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M and Gakis G. Impact of Preoperative Anemia on Oncologic Outcomes of Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. J Urol. 2014 Feb;191(2):316-22.
  • Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers A and Shariat SF. PREDICTORS OF SURVIVAL IN PATIENTS WITH DISEASE RECURRENCE FOLLOWING RADICAL NEPHROURETERECTOMY. BJU Int. 2014 Jun;113(6):911-7.
  • Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS and Shariat SF; for the UTUC Collaboration. Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool. Eur Urol. 2014 Mar;65(3):650-8.
  • Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM and Gierth M. The Charlson Comorbidity Index predicts outcome of recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder. Urol Int. 2014;93(3):303-10.
  • Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, Pawlik MT, Hansen E, Wieland WF, May M and Denzinger S. The effect of intra- and perioperative allogenic blood transfusion on patients` survival undergoing radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2014 Dec;32(6):1447-53.
  • May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG and Brookman-May S; Mitglieder des „CORONA projects“ und/oder der Projektgruppe „Young Academic Urologists Renal Cancer Group“ der European Association of Urology (EAU). Postoperative prognosis of chromophobic renal cell carcinoma: Comparative analysis of the multinational CORONA database. Urologe A. 2014 Feb;53(2):228-35.
  • May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G and Brookman-May S; CORONA and SATURN projects; Young Academic Urologists Renal Cancer Group. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. J Urol. 2013 Aug;190(2):458-63.
  • Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M and May M. Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic. World J Urol. 2014 Jun;32(3):691-5.
  • Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M. 
  • Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer. 2014 Oct;50(15):2583-91.
  • Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik SH, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' Study: How are Preoperative Patient Characteristics Associated with Urinary Diversion Type After Radical Cystectomy for Bladder Cancer? Ann Surg Oncol. 2015 Mar;22(3):1032-42.
  • Froehner M, Novotny V, Wirth MP, Brookman-May S, Aziz A, May M. External validation of a model to predict locoregional failure after radical cystectomy. Cancer. 2014 Nov 15;120(22):3584.
  • Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Bründl J, Fritsche HM, Hofstädter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S. Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol. 2015 Apr 2. [Epub ahead of print]
  • von Landenberg N, Aziz A, von Rundstedt FC, Dobruch J, Kluth LA, Necchi A, Noon A, Rink M, Hendricksen K, Decaestecker KPJ, Seiler R, Poyet C, Fajkovic H, Shariat SF, Xylinas E, Roghmann F; Young Academic Urologists′ Working Group on Urothelial Cancer of the European Association of Urology. Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer. Urol Oncol. 2018 May;36(5):238.e19-238.e27.
  • Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2016 Feb;14(1):96-104.
  • Breyer J, Gierth M, Shalekenov S, Aziz A, Schäfer J, Burger M, Denzinger S, Hofstädter F, Giedl C, Otto W. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma. World J Urol. 2016 May;34(5):709-16
  • May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD; PROMETRICS 2011 Research Group. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. World J Urol. 2017 Feb;35(2):245-250.
  • Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C. The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians. Clin Genitourin Cancer. 2017 Jun;15(3):356-362.
  • Breyer J, Shalekenov S, Aziz A, van Rhijn BWG, Bründl J, Lausenmeyer E, Schäfer J, Denzinger S, Giedl C, Burger M, Hartmann A, Evert M, Otto W. Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer. Bladder Cancer. 2017 Jul 27;3(3):173-180.
  • Hendricksen K, Aziz A, Bes P, Chun FK, Dobruch J, Kluth LA, Gontero P, Necchi A, Noon AP, van Rhijn BWG, Rink M, Roghmann F, Rouprêt M, Seiler R, Shariat SF, Qvick B, Babjuk M, Xylinas E; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. Eur Urol Focus. 2017 Oct 23. pii: S2405-4569(17)30206-7.
  • Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P. The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2017 Dec;35(12):671.e17-671.e23.
  • Duquesne I, Weisbach L, Aziz A, Kluth LA, Xylinas E; Young Academic Urologist Urothelial Carcinoma Group of the European Association of Urology. The contemporary role and impact of urine-based biomarkers in bladder cancer. Transl Androl Urol. 2017 Dec;6(6):1031-1042.
  • Foerster B, Moschini M, Abufaraj M, Soria F, Gust KM, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Kluth L, Mathieu R, Margulis V, Lotan Y, Aziz A, John H, Shariat SF; UTUC Collaboration. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2017 Dec;15(6):e1039-e1045.
  • Gierth M, Zeman F, Denzinger S, Vetterlein MW, Fisch M, Bastian PJ, Syring I, Ellinger J, Müller SC, Herrmann E, Gilfrich C, May M, Pycha A, Wagenlehner FM, Vallo S, Bartsch G, Haferkamp A, Grimm MO, Roigas J, Protzel C, Hakenberg OW, Fritsche HM, Burger M, Aziz A, Mayr R. Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study. Urol Int. 2018;101(1):16-24.
  • Kluth LA, Xylinas E, Rieken M, Kent M, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Bing MT, Gupta A, Sewell JM, Konety BR, Todenhöfer T, Schwentner C, Masson-Lecomte A, Vordos D, Roghmann F, Noldus J, Razmaria AA, Smith ND, Comploj E, Pycha A, Rink M, Baniel J, Mano R, Novara G, Aziz A, Fritsche HM, Brisuda A, Bivalacqua T, Gontero P, Boorjian SA, Vickers AJ, Shariat SF. Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. Eur Urol Focus. 2015 Aug;1(1):75-81.
  • Voskuilen CS, Seiler R, Rink M, Poyet C, Noon AP, Roghmann F, Necchi A, Aziz A, Lavollé A, Young MJ, Marks P, Saba K, van Rhijn BWG, Fransen van de Putte EE, Ablat J, Black PC, Sosnowski R, Dobruch J, Kumar P, Jallad S, Catto JWF, Xylinas E, Hendricksen K. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes. Eur Urol Focus. 2018 Dec 14;. doi: 10.1016/j.euf.2018.12.002. [Epub ahead of print] PubMed PMID: 30559065.
  • Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan WS, Kelly JD, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz PI, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Sooriakumaran P, Shariat SF. Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. Urol Oncol. 2019 Mar;37(3):179.e1-179.e7. doi: 10.1016/j.urolonc.2018.10.012. Epub 2018 Nov 14. PubMed PMID: 30446442. 
  • Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D'Andrea D, Tan WS, Kelly JD, Simone G, Gallucci M, Meraney A, Krishna S, Konety BR, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz PI, Rouprêt M, Koupparis A, Scherr DS, Ploussard G, Sooriakumaran P, Shariat SF, Moschini M. Differences in utilization-trend and time changes of peri-operative outcomes of robotic and open radical cystectomy between American and European selected centers: an international multicenter collaboration. BJU Int. 2019 May 4;. doi: 10.1111/bju.14791. [Epub ahead of print] PubMed PMID: 31055865.

                                                                                                                          Übersichtsarbeiten:

  • Aziz A, Kempkensteffen C, May M, Lebentrau S, Burger M, Chun FK and Brookman-May S. Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer. Expert Rev Anticancer Ther. 2015 Jun;15(6):649-66.
  • Aziz A, Dobruch J, Hendricksen K, Kluth LA, Necchi A, Noon A, Rink M, Roghmann F, Seiler R, Gontero P, Kassouf W, Shariat SF, Xylinas E; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. World J Urol. 2017 Sep;35(9):1401-1407

                                                                                                                               Editorials:

  • Aziz A, Schmid M. Some like it safe. BJU Int. 2016 Apr;117(4):546-7.
  • Aziz A, May M, Hakenberg OW, Brookman-May SD. Re: Differences in Survival Associated with Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. Eur Urol. 2018 Jul 20. pii: S0302-2838(18)30529-3.
  • Froehner M, Novotny V, Wirth MP, Brookman-May S, Aziz A, May M. External validation of a model to predict locoregional failure after radical cystectomy. Cancer. 2014 Nov 15;120(22):3584

                                                                                                                               Buchbeiträge: 

  • Aziz A, Burger M, Roesch WH. Buch: Urology at a glance (1st edition; 2014). Kapitel: Maldescensus testis – from diagnosis to therapy. Verleger: Springer.
  • Zamboni S, Moschini M, Aziz A. Buch: Urologic Oncology (1st edition, 2019). Kapitel: Transurethral Resection of Bladder Cancer and Its Applications. Verleger: Springer.
     

Mitgliedschaften / Reviewer

Mitgliedschaften in Fachgesellschaften

  • Bayerische Urologenvereinigung (BUV) 
  • Deutsche Gesellschaft für Urologie (DGU)
  • European Association of Urology (EAU)
  • European Society of Oncological Urology (ESOU)
  • European Society of Sexual Medicine (ESSM)
  • German Society of Residents in Urology (GeSRU)
  • The Society of Endourology
  • Vereinigung Norddeutscher Urologen (VNU)

Reviewer für Fachzeitschriften

  • Annals of Surgical Oncology
  • Annals of Oncology
  • Asian Journal of Urology
  • Arab Journal of Urology
  • British Journal of Cancer
  • British Journal of Urology
  • Der Urologe
  • European Urology
  • European Urology Focus
  • European Urology Oncology
  • Experts’ Review in Urology
  • International Urology and Nephrology
  • Korean Journal of Urology
  • Nature Reviews in Urology
  • Oncology
  • Oncotarget
  • Scandinavian Journal of Urology
  • The Journal of Urology
  • Urologia Internationalis
  • Urologic Oncology
  • World Journal of Urology

Boardmitgliedschaften

  • Mitglied der GeSRU Academics der German Society of Residents in Urology,
  • Sektion: Blasenkarzinom klinisch und experimentell
  • Mitglied der Young Academic Urologists Working Group der European Association of Urology

Wissenschaftliche Auszeichnungen und Preise

  • Verleihung des Rudolf-Hohenfellner-Preises als bester Nachwuchsurologe unter 35 Jahren durch die Deutsche Gesellschaft für Urologie im Rahmen des 69. Kongresses der Deutschen Gesellschaft für Urologie am 22.09.2017
  • Wissenschaftspreis der Vereinigung der Norddeutscher Urologen e.V. in der Sitzung ,,Fortgeschrittenes Harnblasenkarzinom” im Rahmen des 10. Nordkongress Urologie in Berlin am 17.06.2016: „Extranodale Extension und Lymphknoten-Dichte bei Patienten mit lymphogene metastasierten Urothelkarzinom der Harnblase nach radikaler Zystektomie“ 
  • Best Poster of the Session in der Sitzung „Cystectomy: Optimising perioperative care“ im Rahmen des 31. Kongresses der Europäischen Gesellschaft für Urologie in München am 13.03.2016: „Hospital but not surgical volume predicts 30- and 90-day complications in radical cystectomy (RC) – results from the prospective multicenter radical cystectomy series (PROMETRICS 2011) study group“
  • Best Abstract by a Resident im Rahmen des 31. Kongresses der Europäischen Gesellschaft für Urologie in München am 13.03.2016: „Discrepancy between guidelines and daily practice in the management of non-muscle-invasive bladder cancer (NMIBC): Results of a European survey”
  • Posterpreis der Bayerischen Urologenvereinigung e.V. und Österreichischen Gesellschaft für Urologie und Andrologie in Erlangen am 15.05.2014: „Externe Validierung und Generierung eines präoperativen Nomogramms zur Prädiktion der 90-Tage Mortalität nach Radikaler Zystektomie – Ergebnisse einer prospektiv erfassten multizentrischen Kohorte“
  • Glanzlicht biomedizinischer Forschung des Universitätsklinikum Regensburg 03/2014: „Nomogramme bei Radikaler Zystektomie“
  • Bestes Poster in der Sitzung „Urothelkarzinom: Therapie invasiver Tumore“ im Rahmen des 64. Kongresses der Deutschen Gesellschaft für Urologie in Leipzig am 28.09.2012: „Erstbeschreibung der perinodalen lymphovaskulären Invasion als Prognosefaktor des lymphogen metastasierten Urothelkarzinoms der Harnblase: Ergebnisse einer Multi-Centerstudie nach histopathologischer Re-Evaluierung“

Vorgestellt: Unsere urologische Klinik im Überblick